Partnership For Cures
Partnership For Cures
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for Partnership For Cures? Learn more here.
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.
About this organization
Mission
Cures Within Reach improves patient quality and length of life by leveraging the unrealized clinical potential and missed therapeutic opportunities of existing medicine and science. We leverage the speed, safety and cost-effectiveness of medical repurposing research, driving more treatments to more patients more quickly by clinically testing approved drugs, devices and nutraceuticals for unsolved disease indications that serve commercial and/or philanthropic need.
About
REPURPOSING RESEARCH:ITS MAIN AREA OF FOCUS, THE ORGANIZATION CATALYZES REPURPOSING RESEARCH OPPORTUNITIES BY FACILITATING RESEARCH FUNDING AMONG REPURPOSING STAKEHOLDERS, AND SOLICITING AND VETTING REPURPOSING RESEARCH. IN FY2019, 10 NEW REPURPOSING PROJECTS WERE SIGNED (IN RARE DISEASES, ONCOLOGY, NEUROLOGICAL AND OTHER DISEASES), WHILE 6 PROJECTS WERE COMPLETED (IN NEUROLOGICAL, RARE AND OTHER DISEASES), AND 12 PROJECTS STILL IN PROGRESS - FOR A TOTAL OF 22 ONGOING PROJECTS AS OF 7/31/2019.REGROW PILOT:DURING FY2019, THE ORGANIZATION CONTINUED WORK WITH MANY EXTERNAL VOLUNTEER STAKEHOLDERS TO DEVELOP AND PLAN THE REGROW PILOT PROGRAM. THE PILOT WILL PROVIDE REPURPOSING RESEARCH GRANTS TO CLINICIANS AND RESEARCHERS IN THE DEVELOPING WORLD (DEFINED AS LOW AND LOW-MIDDLE INCOME COUNTRIES PER THE WORLD BANK) TO BUILD CAPACITY FOR RESEARCH FROM WITHIN THE DEVELOPING WORLD AND FIND TREATMENTS FOR THE DEVELOPING WORLD. IN MAY 2019, A CUREACCELERATOR LIVE! FOR THE DEVELOPING WORLD EVENT WAS HELD IN BOSTON. THE ORGANIZATION EXPECTS TO LAUNCH THE FUNDING OPPORTUNITY RFP FOR REGROW IN LATE CY2019.CUREACCELERATOR LIVE!:CUREACCELERATOR LIVE! IS THE ORGANIZATION'S UNIQUE PHILANTHROPIC PITCH EVENT THAT BRINGS TOGETHER STAKEHOLDERS FROM PHARMA, BIOTECH, ACADEMIA, MEDICINE, PHILANTHROPY AND PATIENT GROUPS TO SHOWCASE REPURPOSING PROJECTS IN NEED OF FUNDING. CLINICAL RESEARCHERS ARE SELECTED AS FINALISTS THROUGH AN EXTERNALLY VETTED PROCESS AFTER PROPOSAL SUBMISSIONS. FINALISTS PITCH THEIR CLINICAL REPURPOSING TRIALS AT THE EVENT AND ATTENDEES VOTE FOR THE WINNING REPURPOSING CLINICAL TRIAL. THE WINNING PROJECT IS ANNOUNCED AT THE EVENT ALONG WITH A GRANT COMMITMENT FROM THE ORGANIZATION. IN FY2019, THE ORGANIZATION HELD THREE CUREACCELERATOR LIVE! PITCH EVENTS: ON THE MID-ATLANTIC OUTSIDE OF WASHINGTON DC IN OCTOBER; ON THE DEVELOPING WORLD IN BOSTON IN MAY; AND ON RARE DISEASES IN PHILADELPHIA IN JUNE
Interesting data from their 2020 990 filing
The mission of the non-profit, as stated in the filing, is “Cures within reach improves patient quality and length of life by leveraging the speed, safety and cost-effectiveness of medical repurposing research, driving more treatments to more patients more quickly.”.
When referring to its tasks, they were described as: “To help patients by raising funds to find, vet, finance & manage pilot human clinical research that repurposes drugs, devices & other products that deliver fast,safe, & affordable treatments for both common & rare disorders that do not have a current effective treatment.”.
- The non-profit is operating legally in the state of IL.
- The non-profit's address for the year 2020 is listed as 134 N LASALLE STREET STE 1130, CHICAGO, IL, 60602 in the filing.
- The form submitted by the non-profit organization for 2020 reports 5 employees.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is -$201,055.
- The organization has 9 independent voting members.
- The organization was formed in 2005.
- The organization pays $568,764 in salary, compensation, and benefits to its employees.
- The organization pays $92,107 in fundraising expenses.